What is PHGE (PHGE) stock price today?

PHGE (PHGE) is currently trading at $1.85, up 14.2% today.

What is PHGE P/E ratio?

PHGE's P/E ratio is -0.01. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is PHGE return on equity (ROE)?

PHGE's return on equity (ROE) is -947.73%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is PHGE's market cap?

PHGE has a market capitalization of $1.88M.

AMEX · Biotechnology

PHGE (PHGE) Stock

$1.85 +14.20% AMEX: PHGE Healthcare

Valuation

Metric	Value
Price	$1.85
Market Cap	$1.88M
P/E Ratio	-0.01
P/B Ratio	0.12
P/S Ratio	4.00
EPS (TTM)	$-12.58
52-Week High	$12.29
52-Week Low	$0.12
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-947.73%
ROA	-161.13%
ROCE	-124.63%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.31
Current Ratio	1.00

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-35.0M	$-27.0M	$-28.0M	$-39.0M	$-33.0M
Net Profit	$-36.0M	$-28.0M	$-26.0M	$-18.0M	$-36.0M
EPS	$-264.67	$-180.31	$-96.90	$-27.93	$-22.19
Op Margin	—	—	—	—	—

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$78.0M	$46.0M	$25.0M	$43.0M	$70.0M
Total Liabilities	$30.0M	$24.0M	$22.0M	$19.0M	$72.0M
Cash	$62.0M	$31.0M	$15.0M	$18.0M	$5.0M
Borrowings	$20.0M	$19.0M	$15.0M	$10.0M	$1.0M

Latest News

BiomX: Zorronet Completes Transition to New Advanced Data Center Supporting Business Expansion and Enhanced AI Capabilities GlobeNewswire · Jul 10, 2026 BiomX Signs Non-Binding Letter of Intent to Acquire Control of Revenue-Generating Security Infrastructure and Systems Integration Company, Expanding Its Security Platform with Critical Infrastructure and Secure-Site Integration Capabilities GlobeNewswire · Jul 8, 2026 BiomX: Subsidiary Zorronet Commences Installation and Operation of AI-Powered Detection Systems Under Israel Railways Agreement GlobeNewswire · Jul 6, 2026 BiomX: Next-Gen Counter Drone Solutions will be Showcased by DFSL at ISC 2026 GlobeNewswire · Jun 24, 2026 BiomX Provides Update on Defense Technology Portfolio and Growth Strategy GlobeNewswire · Jun 18, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-28.0M	$-29.0M	$-21.0M	$-37.0M	$-26.0M
Investing Cash Flow	$12.0M	$-2.0M	$2.0M	$1.0M	$0
Financing Cash Flow	$0	$0	$0	$28.0M	$0
Net Cash Flow	$26.0M	$-31.0M	$-16.0M	$2.0M	$-13.0M
Free Cash Flow	$-31.0M	$-29.0M	$-21.0M	$-37.0M	$-26.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.18
FCF Yield	-1366.02%
Quick Ratio	0.24
Interest Coverage	-27.30
Return 1Y	-97.23%
Return 3Y	-99.72%
Return 5Y	-99.98%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ADAPAdaptimmune Therapeutics plc	$0.05	-3.00%	-0.16	$75.16M	0.00%
BRTXBioRestorative Therapies, Inc.	$1.59	-9.14%	-0.10	$2.20M	0.00%
DWTXDogwood Therapeutics, Inc.	$1.30	-5.11%	-0.18	$43.72M	0.00%
EDSAEdesa Biotech, Inc.	$2.85	-3.23%	-2.28	$27.41M	0.00%
ERNAErnexa Therapeutics Inc.	$2.21	+0.00%	-0.15	$3.61M	0.00%

About PHGE

PHGE is led by CEO Marina Wolfson, employs 20 people, headquartered in US, publicly traded since 2019.

PHGE stock trades at $1.85 with a market capitalization of $1.88M. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.01, reflecting a net loss over the last twelve months, price-to-book of 0.12, price-to-sales of 4.00. Over the past 52 weeks the stock has ranged between $0.12 and $12.29, and currently trades 85.0% below its 52-week high.

On profitability, PHGE generates a return on equity (ROE) of -947.73% (negative, reflecting a net loss), return on capital employed of -124.63%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1166.51 -1.36% JNJ Johnson & Johnson $248.61 -5.73% ABBV AbbVie Inc. $274.31 -2.42% MRK Merck & Company, Inc. Common Stock (new) $141.98 -2.39% UNH UnitedHealth Group Incorporated Common Stock (DE) $377.76 -0.20% NVS Novartis AG $142.41 -0.99% TMO Thermo Fisher Scientific Inc $663.04 +0.12% AZN AstraZeneca PLC $155.82 -1.59% AMGN Amgen Inc. $412.84 -1.13% GILD Gilead Sciences, Inc. $147.92 -1.67% ABT Abbott Laboratories $102.67 +0.83% NVO Novo Nordisk A/S $38.06 -1.35%

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.